Chronic myeloproliferative diseases with concurrent BCR–ABL junction and JAK2V617F mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic myeloproliferative diseases with concurrent BCR–ABL junction and JAK2V617F mutation

Published:2007-11-01 Issue:5 Volume:22 Page:1059-1062
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hussein K,Bock O,Theophile K,Seegers A,Arps H,Basten O,Grips K-H,Franz-Werner J,Büsche G,Kreipe H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404993.pdf

Reference8 articles.

1. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092–1097.

2. Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Büsche G et al. Myelofibrosis evolving during Imatinib treatment of a chronic myeloproliferative disease with co-existing BCR–ABL translocation and JAK2V617F mutation. Blood 2007; 109: 4106–4107.

3. Kramer A, Reiter A, Kruth J, Erben P, Hochhaus A, Muller M et al. JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol 2007; 8: 658–660.

4. Bornhauser M, Mohr B, Oelschlaegel U, Bornhauser P, Jacki S, Ehninger G et al. Concurrent JAK2(V617F) mutation and BCR–ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia 2007; 21: 1824–1826.

5. Inami M, Inokuchi K, Okabe M, Kosaka F, Mitamura Y, Yamaguchi H et al. Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia. Leukemia 2007; 21: 1103–1104.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination;Frontiers in Oncology;2024-01-12

2. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child;Laboratory Medicine;2023-06-23

3. BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia;Blood Science;2022-08-01

4. Rare Case of Accelerated-Phase Chronic Myeloid Leukemia Diagnosed During Treatment for JAK2 V617F–Positive Primary Myelofibrosis;Laboratory Medicine;2022-03-04

5. A case of double positive myeloproliferative neoplasm;Indian Journal of Pathology and Microbiology;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3